A Spanish study found that nirsevimab prophylaxis significantly reduced infant hospitalizations, ICU admissions, and severe ...

In 2023, U.S. health officials began recommending two new measures to prevent the toll on infants -- one was a lab-made ...

Far fewer babies had severe cases of the respiratory illness RSV, in a winter in which a new monoclonal and vaccine became ...

For a broader group of infants—0 to 7 months old—RSV-NET showed a 43 percent drop in hospitalizations in the 2024–2025 RSV season, and NVSN saw a 28 percent drop. Again, when Houston was excluded from ...

Here's what RSV is, why it especially impacts the youngest and oldest members of society and how it is usually treated.

HealthDay News — In a recent study of a population of infants, published online May 6 in Pediatrics, 72% of infants were found to be immunized against respiratory syncytial virus (RSV).

The ancestor of the virus that causes COVID-19 left its point of origin in Western China or Northern Laos just several years ...

Most infants hospitalised for RSV-related infections need oxygen support and critical care despite nirsevimab use, with ...

The overall uptake of RSV vaccine is low during its first season in those aged 60 years or older in the United States. The ...

The health and human services secretary, Robert F. Kennedy Jr., is known for his criticism of advisory panels, most recently ...

After the monoclonal antibody nirsevimab (Beyfortus) became available to prevent respiratory syncytial virus (RSV) in infants ...